Exosomal hsa_circ_0125310 promotes cell proliferation and fibrosis in diabetic nephropathy via sponging miR-422a and targeting the IGF1R/p38 axis
- PMID: 34854210
- PMCID: PMC8742240
- DOI: 10.1111/jcmm.17065
Exosomal hsa_circ_0125310 promotes cell proliferation and fibrosis in diabetic nephropathy via sponging miR-422a and targeting the IGF1R/p38 axis
Abstract
Diabetic nephropathy (DN) is still on the rise worldwide, and millions of patients have to be treated through dialysis or transplant because of kidney failure caused by DN. Recent reports have highlighted circRNAs in the treatment of DN. Herein, we aimed to investigate the mechanism by which high glucose-induced exo-circ_0125310 promotes diabetic nephropathy progression. circ_0125310 is highly expressed in diabetic nephropathy and exosomes isolated from high glucose-induced mesangial cells (MCs). High glucose-induced exosomes promote the proliferation and fibrosis of MCs. However, results showed that the effects of exosomes on MCs can be reversed by the knockdown of circ_0125310. miR-422a, which targets IGF1R, was the direct target of circ_0125310. circ_0125310 regulated IGF1R/p38 axis by sponging miR-422a. Exo-circ_0125310 increased the luciferase activity of the WT-IGF1R reporter in the dual-luciferase reporter gene assays and upregulated the expression level of IGF1R and p38. Finally, in vivo research indicated that the overexpression of circ_0125310 promoted the diabetic nephropathy progression. Above results demonstrated that the high glucose-induced exo-circ_0125310 promoted cell proliferation and fibrosis in diabetic nephropathy via sponging miR-422a and targeting the IGF1R/p38 axis.
Keywords: MCs; diabetic nephropathy; fibrosis; hsa_circ_0125310; proliferation.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures







Similar articles
-
Exosomal circ_DLGAP4 promotes diabetic kidney disease progression by sponging miR-143 and targeting ERBB3/NF-κB/MMP-2 axis.Cell Death Dis. 2020 Nov 23;11(11):1008. doi: 10.1038/s41419-020-03169-3. Cell Death Dis. 2020. PMID: 33230102 Free PMC article.
-
Circ_0123996 promotes the proliferation, inflammation, and fibrosis of mesangial cells by sponging miR-203a-3p to upregulate SOX6 in diabetic nephropathy.J Biochem Mol Toxicol. 2022 Nov;36(11):e23139. doi: 10.1002/jbt.23139. Epub 2022 Sep 8. J Biochem Mol Toxicol. 2022. PMID: 36073553
-
CircRNA Arf3 suppresses glomerular mesangial cell proliferation and fibrosis in diabetic nephropathy via miR-107-3p/Tmbim6 axis.J Bioenerg Biomembr. 2024 Oct;56(5):543-552. doi: 10.1007/s10863-024-10027-w. Epub 2024 Aug 9. J Bioenerg Biomembr. 2024. PMID: 39120858 Free PMC article.
-
Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.Stem Cell Res Ther. 2022 Jan 24;13(1):25. doi: 10.1186/s13287-021-02696-w. Stem Cell Res Ther. 2022. PMID: 35073973 Free PMC article. Review.
-
The role of circular RNA in Diabetic Nephropathy.Int J Med Sci. 2022 May 20;19(5):916-923. doi: 10.7150/ijms.71648. eCollection 2022. Int J Med Sci. 2022. PMID: 35693742 Free PMC article. Review.
Cited by
-
Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases.J Nanobiotechnology. 2023 May 24;21(1):164. doi: 10.1186/s12951-023-01921-3. J Nanobiotechnology. 2023. PMID: 37221595 Free PMC article. Review.
-
Research progress on non-coding RNA regulatory networks and targeted therapy in diabetic nephropathy.Front Endocrinol (Lausanne). 2025 Jul 29;16:1625307. doi: 10.3389/fendo.2025.1625307. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40801037 Free PMC article. Review.
-
Circular RNAs and the regulation of gene expression in diabetic nephropathy (Review).Int J Mol Med. 2024 May;53(5):44. doi: 10.3892/ijmm.2024.5368. Epub 2024 Mar 22. Int J Mol Med. 2024. PMID: 38516776 Free PMC article.
-
Role of exosomes in pathogenesis, diagnosis, and treatment of diabetic nephropathy.BMC Nephrol. 2025 May 8;26(1):230. doi: 10.1186/s12882-025-04120-4. BMC Nephrol. 2025. PMID: 40340661 Free PMC article. Review.
-
Specific expression profile of follicular fluid-derived exosomal microRNAs in patients with diminished ovarian reserve.BMC Med Genomics. 2023 Nov 30;16(1):308. doi: 10.1186/s12920-023-01756-9. BMC Med Genomics. 2023. PMID: 38037065 Free PMC article.
References
-
- Dewanjee S, Bhattacharjee N. MicroRNA: A new generation therapeutic target in diabetic nephropathy. Biochem Pharmacol. 2018;155:32‐47. - PubMed
-
- Lv M, Chen Z, Hu G, Li Q. Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives. Drug Discovery Today. 2015;20:332‐346. - PubMed
-
- Zha D, Wu X, Gao P. Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential. Endocrinology. 2017;158:2022‐2034. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical